NeuExcell Therapeutics’ brain cancer therapy tests debated fieldnews2026-02-18T12:00:07+00:00February 18th, 2026|Endpoints News|
Gilead gets cancer drug from China-based Genhouse for $80M upfrontnews2026-02-13T18:53:40+00:00February 13th, 2026|Endpoints News|
Pentagon adds, then withdraws, WuXi AppTec to Chinese military listnews2026-02-13T18:48:38+00:00February 13th, 2026|Endpoints News|
Former AstraZeneca senior staff charged with illegal trade in Chinanews2026-02-11T20:24:40+00:00February 11th, 2026|Endpoints News|
Madrigal pads MASH pipeline with six siRNAs from China’s Ribonews2026-02-11T15:49:41+00:00February 11th, 2026|Endpoints News|
Sanofi invests in China startup GluBio in developing molecular glue for sickle cellnews2026-02-11T12:00:02+00:00February 11th, 2026|Endpoints News|
Shanghai’s Cascade gets $72M to pursue MASH, obesity and diabetes drugsnews2026-02-10T15:50:13+00:00February 10th, 2026|Endpoints News|
Hengrui, Kailera push obesity pill ahead on promising mid-stage China datanews2026-02-10T12:00:31+00:00February 10th, 2026|Endpoints News|
Lilly returns to Innovent to partner on cancer and immune diseasesnews2026-02-09T09:28:38+00:00February 9th, 2026|Endpoints News|
Angitia gets $130M Series D for pipeline of musculoskeletal drugsnews2026-02-05T12:30:10+00:00February 5th, 2026|Endpoints News|
